ALXN
Alexion Pharmaceuticals
ALXN
ALXN
Delisted
ALXN was delisted on the 20th of July, 2021.
608 hedge funds and large institutions have $20.4B invested in Alexion Pharmaceuticals in 2018 Q4 according to their latest regulatory filings, with 101 funds opening new positions, 200 increasing their positions, 234 reducing their positions, and 71 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
less call options, than puts
Call options by funds: $ | Put options by funds: $
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
31% less capital invested
Capital invested by funds: $29.5B → $20.4B (-$9.09B)
56% less funds holding in top 10
Funds holding in top 10: 18 → 8 (-10)
Holders
608
Holding in Top 10
8
Calls
$184M
Puts
$201M
Top Buyers
| 1 | +$516M | |
| 2 | +$77.1M | |
| 3 | +$64M | |
| 4 |
CCM
Camber Capital Management
Boston,
Massachusetts
|
+$58.4M |
| 5 |
AQR Capital Management
Greenwich,
Connecticut
|
+$44.3M |
Top Sellers
| 1 | -$311M | |
| 2 | -$107M | |
| 3 | -$107M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$88.3M |
| 5 |
O
OrbiMed
New York
|
-$81.2M |